Detection of the oestrogen receptor (ER): Immunohistochemical versus cytosol measurements

European Journal of Cancer

Volumn 36, Issue SUPPL. 4, 2000, Pages 18-19

  Leake, R ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Assay protocol; Breast cancer; Immunohistochemistry; Oestrogen receptor; Therapy

Indexed keywords

ESTROGEN RECEPTOR;

BREAST CARCINOMA; CYTOSOL; HORMONAL THERAPY; HUMAN; IMMUNOHISTOCHEMISTRY; LIGAND BINDING; PRIORITY JOURNAL; QUALITY CONTROL; RECEPTOR DENSITY; SHORT SURVEY;

EID: 0033759808     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0959-8049(00)00208-2     Document Type: Short Survey

References (6)

1. Tamoxifen for early breast cancer: An overview of randomised trials
2. Prediction of hormone sensitivity - The receptor years and onwards
3. Standardization of steroid receptor assays in human breast cancer - IV
4. Increased use of immunohistochemistry for oestrogen receptor measurement
5. Estrogen receptor status by immunohistochemistry is superior to ligand-binding assay for predicting response to adjuvant therapy in breast cancer
6. Immunohistochemical detection of steroid receptors in breast cancer: A working protocol